Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
ADXBLADDER
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Arquer Diagnostics
Type:
Laboratory Developed Test
Related tests:
‹
ADXGYNAE
ADXGYNAE
›
Details
Evidence
News
Search handles
@drenriquegrande
Search handles
@drenriquegrande
Filter by
Latest
over2years
@UroDocAsh is leading our #ADXBLADDER US cancer recurrence study: “Arquer continues to invest in robust studies and if this leads to FDA approval it will be an incredibly useful new tool for us to safely and accurately diagnose and monitor patients.” https://t.co/D8RlXhEjuX (@ArquerDx)
over 2 years ago
FDA event • Clinical
|
ADXBLADDER
almost3years
@ArquerDx are pleased to announce the addition of Maddy Kennedy to their Executive Team. #ArquerDx #ADXBLADDER #Bladdercancer #Diagnostics (@ArquerDx)
almost 3 years ago
ADXBLADDER
4years
"A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria—A Prospective Multicentre Performance Evaluation of ADXBLADDER #bladdercancer https://t.co/oZO1zjOl76" (@drenriquegrande)
4 years ago
Clinical
|
ADXBLADDER
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login